Finance
Beta
search
Search or ask
settings
Theme
mobile
Device default
✓
dark_mode
Dark theme
light_mode
Light theme
Search labs
feedback
Send feedback
Sign in
Lists
playlist_add
New
CD8
Research
CD8:EPA
check_indeterminate_small
Amundi MSCI EMU High Dividend UCITS ETF Acc
€212.35
arrow_upward
+0.26%
(
+0.55
) 1D
Jul 17, 5:35:14 PM GMT+2 · EUR
area_chart
Area
stacked_line_chart
Compare
search
close
All symbols
monitoring
Indicators
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
Symbol
Price
Change
% Change
Overview
insights_auto
Generating top insights for CD8...
Open
€211.90
High
€212.85
Low
€211.65
Avg. vol.
3.08K
Volume
2.24K
52-wk high
€212.85
52-wk low
€169.82
Open
€211.90
High
€212.85
Low
€211.65
Avg. vol.
3.08K
Volume
2.24K
52-wk high
€212.85
52-wk low
€169.82
Related assets
CD9
Amundi MSCI Europe Hgh Dvdnd Factor UCITS ETF EURA
€245.60
+0.57%
arrow_upward
CD5
Inuvo Inc
€0.96
-13.18%
arrow_downward
CCC3
Coca-Cola Co
€72.70
-1.38%
arrow_downward
CE8
Amundi MSCI World Ex Europe UCITS ETF - EUR (C)
€758.71
-1.13%
arrow_downward
News stories
From sources across the web
GlobeNewswire
·
25 minutes ago
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
·
40 minutes ago
Apple Had the Cash to Buy Any of 486 S&P 500 Companies, but Tim Cook Bet $851 Billion on This Instead
Stock Titan
·
19 minutes ago
Vaxart (Nasdaq: VXRT) sees directors re-elected but executive pay vote fails
Seeking Alpha
·
20 minutes ago
3 things to look out for on Monday
Show more
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer
Research
edit_square
New thread
notes_spark
Thread history
close
Collapse
expand_content
Expand
What's on your mind?
What's going on with the markets today?
search_spark
Explore what’s possible
add
Create a portfolio
task_spark
Create a task
travel_explore
Deep Search
mic
Voice Search
add
Add Tool
upload_file
Upload File
bar_chart
Create portfolio
travel_explore
Deep Search
arrow_upward
Ask AI
search_spark
mic
Voice Search
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer